• Alpha-tropomysin (TPM1) Mutation Analysis
  • Sodium, Random, Urine
  • Metabolic Storage Disease Gene Mutation Panel, NGS
  • Fungal Culture, Body Fluid
  • West Nile Virus (WNV) Antibody, IgG
  • Fibroblast Growth Factor Receptor 1 (FGFR1), 8p11.2 Rearrangement, FISH, Bone Marrow
  • Arylsulfatase A, 24 Hour, Urine
  • ESOPREDICT® Barrett's Esophagus Risk Classifier Assay
  • Acquired immunodeficiency syndrome (AIDS)
  • Bordetella Pertussis Antibody, IgA
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Turnaround Time
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.